US equities were mixed on Tuesday, amid weakness in financials and healthcare, although technology offered some respite, and after the closing bell results from Intel exceeded forecasts.

Earnings from Johnson & Johnson and an equity analyst downgrade for Goldman Sachs weighed on sentiment for much of the day and outweighed further weakness in the dollar.